Clinical Trial Update: The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of pioglitazone in patients with nonalcoholic steatohepatitis (NASH).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis
• Viral Hepatitis

Drugs mentioned

• PIOGLITAZONE (Pioglitazone)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Hepatitis | Phase 2 | Status: COMPLETED